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Abstract: 
Objectives: To determine the frequency of anaemia in patients presenting with Helicobacter pylori gastritis at Jinnah 
Postgraduate Medical Centre Karachi. 
Material and methods: This descriptive cross sectional study has been conducted in General Medicine ward Jinnah 
Postgraduate Medical Centre, Karachi, with six months duration. All the patients with H pylori gastritis diagnosed on biopsy, 
age between 18-65 years, duration of symptoms of more than 6 months as (epigastric pain, epigastric burning, abdominal 
bloating, nausea, vomiting and confirmed on biopsy as H pylori gastritis), willing to participate in the study either gender were 
included in the study. For the evaluation of anaemia the laboratory investigations were advised complete blood count and serum 
iron profile. Selection criteria were followed strictly to control confounders. 
Results: A total of 115 patients presenting with helicobacter pylori gastritis at Jinnah Postgraduate Medical Centre (JPMC) 
were enrolled in this study. The mean age of patients was 39.20±14.64 years. Males were 70 (60.9%). Mean time duration of 
symptoms of patients was 8.21 ± 3.66 months. The mean hemoglobin% was 12.95 ± 2.10 mg/dL, mean serum ferritin was 63.90 ± 
9.02 63.90+9.02 µg/d+L, Mean of MCV was 87.53 ± 12.48. Over all frequency of anaemia in patients presenting with 
helicobacter pylori gastritis, was 29(25.2%). Following by iron deficiency anaemia was in 16 cases, pernicious anaemia in 7 
cases, while both type of anaemia was found in 6 cases.  No significant difference was found according to gender in anemia in H-
pylori infected patients P- value = 0.87.  
Conclusion: In H pylori gastritis patients’ anemia was present in one forth of cases (25%), among them commonest was iron 
deficiency anemia 13%.  
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INTRODUCTION: 
Helicobacter pylori (H pylori) are spiral gram 
negative bacterium which colonizes the mucosa of 
stomach. It is estimated that about two third of 
world’s population is infected with this organism1 
and it is responsible for > 80 % cases of chronic 
gastritis and peptic ulcer diseases throughout the 
world.2,3 H pylori can infect any age and is more 
commonly seen in patients of low socio-economic 
status in developing countries.4 In Pakistan the 
infection rate of H pylori is 83% in general 
population.5 It is estimated that in Pakistan 80% of 
infants acquire this infection within their first month 
of life.6 H pylori is responsible for 53% of duodenal 
ulcers and anaemia in upto 14% patients in 
Pakistan.4,6 H Pylori impairs the normal secretion of 
hydrochloric acid, provoking achlorhydria in infected 
patients. Resulting increased pH and decreased 
concentration of ascorbic acid in stomach leads to 
malabsorption of many micronutrients including iron 
from gastric mucosa.7 Other suggested pathogenesis 
is the increased iron loss from micro bleeding, and its 
utilization by H pylori.8 This leads to iron deficiency 
anaemia. WHO statistics show that 1.62 billion 
people worldwide suffer from anaemia worldwide, 
50% of whom are affected by iron deficiency 
anaemia (IDA).2,9 Iron deficiency anaemia has been 
observed even in those H. pylori infected persons 
who do not have ulcers or cancer. It is suggested that 
eradication of H pylori improves the absorption of 
iron, and produce more rapid and complete clinical 
responses in these patients.10,11 Despite of highly 
sensitive and specific diagnostic techniques and 
effective therapies, H pylori infection is highly 
prevalent in Pakistan so will be the prevalence of 
anaemia in these patients. Upon thorough literature 
search there was only limited data available to 
ascertain the burden of anaemia in H pylori patients. 
The available data is on selected groups of patients 
(only those who underwent upper GI endoscopy) and 
not a general presentation of all patients presenting 
with H pylori infection. This study is based on the 
rationale that present the magnitude of anemia in all 
patients presenting with H pylori infection. 
MATERIAL AND METHODS: 
Study Setting: General Medicine ward-7, Jinnah 
Postgraduate Medical Centre, Karachi 
Duration of Study: Six months  
Study Design: Descriptive cross sectional study 
Sample Size: The expected proportion of iron 
deficiency anaemia in H pylori patients was taken as 
12.14%15, margin of error as 6% and confidence level 
of 95% and using least proportion formula, the 
sample size is 114 ≈ 115. 
Sample selection:  
Inclusion criteria: 
 Patients of both gender with H pylori 
gastritis diagnosed on biopsy 
 Patients with age between 18-65 years 
  Patients of any socio-economic strata 
 Duration of symptoms of more than 6 
months 
 Patients not having psychological disorder 
like depression, schizophrenia 
 Willing to participate in the study 
 Non smokers 
Exclusion criteria: 
 Pregnancy 
 Patients who had laboratory evidence of 
malaria in previous one month 
 Chronic illnesses like chronic liver disease, 
liver cirrhosis, chronic renal failure, 
tuberculosis 
 Blood disorders like thalassaemia, acute 
leukemia, haemoglobinopathies, clotting 
disorders 
 Gastric carcinoma or other cancer 
 Operated upon for gastrostomy, 
jejunostomy, ileostomy and colostomy 
 Patients who are on radiotherapy, 
chemotherapy 
 Patients taking medicine causing folic acid 
deficiency like Gabapentin, Methotrexate, 
Trimethoprim and Pyrimethamine. 
Data Collection Procedure 
The Patients who present to OPD of medical ward-7 
with any one or more of the complaints of epigastric 
pain, epigastric burning, abdominal bloating, nausea, 
vomiting and confirmed on biopsy as H pylori 
gastritis were asked to participate in the study. Those 
who fulfill the inclusion criteria were asked for 
written consent for the study. Consenting patients 
were enrolled in the study. Treatment was given to 
these patients according to the available standard 
therapies practiced at the institution. The researcher 
will gather data on prescribed questionnaire from the 
patients. The data were taken on demographic 
variables like name. age, gender and address. 
Duration of symptoms were noted. For the evaluation 
of anaemia (outcome variable) the following 
laboratory investigations were advised complete 
blood count and serum iron profile. Selection criteria 
were followed strictly to control confounders. The 
data was analyzed after entering it into SPSS-17.  
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RESULTS: 
A total of 115 patients presenting with helicobacter 
pylori gastritis at Jinnah Postgraduate Medical Centre 
(JPMC) were enrolled in this study. The mean age of 
patients was 39.20±14.64 years. According to 
distribution of gender in overall study population, 
males were 70 (60.9%) and females were 45 (39.1%). 
On distribution of socio economic status, low socio 
economic status in 54 (47%) and high socio 
economic status was 61 (53%) shown in Table 1. 
The mean time duration of symptoms of patients was 
8.21 ± 3.66 months. The mean hemoglobin% was 
12.95 ± 2.10 mg/dL, mean serum ferritin was 63.90 ± 
9.02 63.90+9.02 µg/d+L, mean of mean corpuscular 
volume (MCV) was 87.53 ± 12.48 Table 2. 
Over all frequency of anaemia in patients presenting 
with helicobacter pylori gastritis, was 29(25.2%). 
Following by iron deficiency anaemia was in 16 
cases, pernicious anaemia in 7 cases, while both type 
of anaemia was found in 6 cases. Table:3 
No significant difference was found according to 
gender in anemia in H-pylori infected patients (Chi 
square test statistic = 0.023; P- value = 0.87). 
Comparison of frequency of anaemia between time 
duration of symptoms, in (5 – 10) month group was 5 
(17.2%), in (11 – 15) months group was 17 (58.6%) 
and in (16 – 20) months group was 7 (24.1%). This 
comparison found statistically significant (Chi square 
test statistic = 80.32; P- value = <0.001). Table 4. 
Table 1: basic characteristics of study population n=115 
Bassline Characteristics Number Percent 
Age groups 
17 – 30 
31 – 45 
> 46 
41 
32 
42 
35.7% 
27.8% 
36.5% 
Gender 
Male 
Female 
 
45 
70 
 
39.1% 
60.9% 
Socioeconomic status 
Poor 
High class  
 
54 
61 
 
 
47.0% 
53.0% 
 
Table 2: Mean level of anemia and time duration of symptoms of study 
n= 115 
ANEMIA AND TIME DURATION MEAN + SD 
Time duration of symptoms 8.21+3.66 month 
Hemoglobin  12.95+2.10 mg/dL 
Seum Ferrtitin  63.90+9.02 µg/d+L 
Mean Corpuscular Volume (MCV) 87.53+12.48  
Table 3: Frequency of anemia of study in population n= 29 
TYPES OF ANEMIA frequency % 
IRON DEFICIENCY ANEMIA 16 13.9% 
PERNICIOUS ANEMIA 07 6.1% 
BOTH ANEMIA 06 5.2% 
Total (Over all anemia)  29 25.2% 
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Table 4: distribution of anemia according To gender n=115 
ANEMIA Not ANEMIAC ANEMIAC 
GENDER N % N % 
FEMALE 34 39.5 11 37.9 
MALE 52 60.5 18 62.1 
Chi square test statistic = 0.023; P- value = 0.87 
 
Table 5: Distribution of Anemia According To Duration of Symptoms (MONTHS) n=115 
ANEMIA Not ANEMIAC ANEMIAC 
DURATION OF SYMPTOMS N % N % 
5 - 10 84 97.7 5 17.2 
11 - 15 1 1.2 17 58.6 
16 - 20 1 1.2 7 24.1 
Chi square test statistic = 80.32; P- value = <0.001 
 
DISCUSSION: 
Iron deficiency and Iron deficiency anemia are 
important health conditions with important health 
consequences regarding reproduction, immunity, 
work performance, and possibly cognitive 
development; it is a simple result of an imbalance 
between iron loss and absorption.12 Helicobacter 
pylori associated gastritis has emerged as a potential 
cause of iron deficiency anemia that is unresponsive 
to iron therapy.13 Our study results also support that 
H-pylori infection is associated with ID, this relation 
is also supported by many studies with different 
explanation of the mechanisms by which H.pylori 
affect iron absorbance. 
A recent study in the American Journal of 
Epidemiology14, looking at data for 7,462 people, 
reveals that H. pylori might also contribute to one of 
the most common nutritional deficiencies in the 
world. Iron deficiency affects mainly older infants, 
young children, adolescents, and pre-menopausal 
women. Our bodies need iron to manufacture 
hemoglobin, a substance in red blood cells that 
carries oxygen to the cells via the lungs. When 
insufficient iron is present, the body produces smaller 
and fewer red blood cells, resulting in less oxygen 
fuelling the body. This can cause impairments in 
immune, cognitive, and reproductive body functions, 
and in work performance. The biochemical 
mechanism whereby H. pylori cause iron deficiency 
and anemia is unknown. However, the researchers 
suggest that the reduced iron could be due one or 
more of these factors: 
 Use of iron by the bacteria to 
reproduce,  
 Micro-bleeding resulting from H. 
pylori attachments to the stomach wall, 
and/or  
 Decreased iron absorption due to an 
affect of H. pylori on the stomach. 
Researchers suggest that H. pylori are the second 
leading cause of communicable iron deficiency, next 
to worm infestation. H. pylori infection raised the 
risk of iron deficiency by 40% and of IDA by 160%. 
This was after ruling out patients with peptic ulcer 
disease – a known contributor to anemia due to blood 
loss. 
A study including 2080 adult patients in Alaska, 
where there is a high prevalence of H.pylori, have 
suggested a significant correlation between H.pylori–
IgG positivity and low serum ferritin levels.15 They 
have suggested that ulceration causes bleeding which 
leads to IDA and this result was confirmed by our 
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own study. The blood loss in chronic gastritis, and 
bleeding from duodenal or gastric ulcers related to H 
pylori infection, plays an important role in the 
development of iron deficiency in adults. In response 
to H.pylori chronic gastric inflammation, the 
epithelial cells in the mucosa are damaged, leading to 
detachment and apoptosis. In the absence of bleeding 
lesions, the possible mechanisms by which H.pylori 
is involved in the development of IDA remain 
unclear. Moreover, Boggs reviewed that eradication 
of H.pylori with a triple therapy consisting of lan-
soprazole, clarithromycine, and amoxicillin for 14 
days leads to serum ferritin levels elevation sig-
nificantly in both IDA and ID groups without iron 
supplements, indicating that complete recovery of 
iron deficiency and iron deficiency anemia can be 
achieved with the treatment of H.pylori infection.16  
 
CONCLUSION:  
Over all frequency of anemia in patients with H 
pylori gastritis was found to be 25%, among them 
iron deficiency anemia was most common 13%. High 
index of suspicion for iron deficiency should be 
exercised in these patients to avoid the hematological 
and neurological complications. 
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